首页 | 本学科首页   官方微博 | 高级检索  
     

TIL细胞治疗恶性胸水的疗效观察
引用本文:陈建清,曾道林,康美玲,钟小红,董书春,刘进兵,吴晓安. TIL细胞治疗恶性胸水的疗效观察[J]. 中国肿瘤临床与康复, 2011, 0(1): 56-57
作者姓名:陈建清  曾道林  康美玲  钟小红  董书春  刘进兵  吴晓安
作者单位:解放军第一七四医院肿瘤中心二区;
摘    要:目的观察肿瘤浸润淋巴细胞(TIL)治疗恶性胸水的疗效。方法从30例恶性肿瘤胸水中的肿瘤细胞分离得到TIL,并经10%人AB血清RPM I-1640液培养,经rIL-2体外激活培养,随后胸腔注射。结果完全缓解12例(40.0%),有效15例(50.0%),无效3例(10.0%),总有效率90.0%(27/30)。结论 TIL治疗恶性胸腔积液疗效好,毒副作用小,能改善患者的生活质量。

关 键 词:恶性肿瘤  肿瘤浸润细胞  白细胞介素-2  胸腔积液  穿刺术

Observation of efficacy of tumor infiltrating lymphocytes in treatment of malignant pleural effusion
CHEN Jian-qing,ZENG Dao-lin,KANG Mei-ling,et al. Observation of efficacy of tumor infiltrating lymphocytes in treatment of malignant pleural effusion[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2011, 0(1): 56-57
Authors:CHEN Jian-qing  ZENG Dao-lin  KANG Mei-ling  et al
Affiliation:CHEN Jian-qing,ZENG Dao-lin,KANG Mei-ling,et al(The Second Ward of Oncology Department,174th PLA Hospital,Xiamen 361003,China)
Abstract:Objective To evaluate the efficacy of tumor infiltrating lymphocytes(TIL)in treatment of patients with malignant pleural effusion.Methods TILs derived from malignant pleural effusion of 30 patients were cultivated in 10% human AB type serum RPMI-1640 liquid medium,activated by rIL-2 in vitro and injected into thoracic cavities.Results CR 12(40.0%),PR 15(50.0%),NR 3(10.0%).Conclusion The result suggests that TILs derived from malignant pleural effusion have good therapeutic efficacy and is safe in patients w...
Keywords:Malignant tumor  Tumor infiltrating lymphocytes(TIL)  Interleukin 2(IL-2)  Pleural effusion  Puncture  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号